d-alpha tocopherol has been researched along with gambogic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussain, MD; Saxena, V | 1 |
| Bodman, A; Guo, D; Huang, W; Luo, J; Shi, C; Wang, L; Wang, X; Xu, G | 1 |
2 other study(ies) available for d-alpha tocopherol and gambogic acid
| Article | Year |
|---|---|
Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Micelles; Nanocapsules; Particle Size; Poloxamer; Polyethylene Glycols; Vitamin E; Xanthones | 2012 |
Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Dendrimers; Drug Carriers; Drug Delivery Systems; Drug Design; Female; HCT116 Cells; Hemolysis; Humans; Light; MCF-7 Cells; Mice; Mice, Nude; Micelles; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Neoplasm Transplantation; Polyethylene Glycols; Scattering, Radiation; Solubility; Vitamin E; Xanthones | 2015 |